Oct 6, 2023 | Case Study, Company News
Executive Summary Exom, a digital-first contract research organization (CRO), worked with AWS Partner Storm Reply to build a reliable and compliant chatbot using artificial intelligence (AI) on Amazon Web Services (AWS). The solution guides remote participants using...
Aug 3, 2021 | Articles, Case Study, Clinical Trial News, Company News
Having made a name for itself as the ‘Most Innovative Full-Service CRO’ for 2021, the Exom Group has been pushing for the acceptance of digital and technological solutions in Clinical Trials. Whilst there is still a lot of work to be done before the field embraces the...
Nov 30, 2020 | Case Study, Company News, Genius Suite
Digital technologies have been used in clinical studies for years. So far, however, they have been used very hesitantly by sponsors, study centers and CROs. Authorities have also been very hesitant to approve their use. The Covid-19 pandemic, however, has changed this...
Apr 7, 2020 | Articles, Case Study, Company News
Exom Group is proud to announce that the results of CARAVAGGIO, a practice-changing study, have been presented at the ACC Virtual 2020 and published on the NEJM on March 29th, 2020. DOI: 10.1056/NEJMoa1915103 The study involved 159 clinical sites distributed in 9...
Nov 13, 2019 | Articles, Case Study, Company News
Despite the opportunities offered by the digital revolution of recent decades, the organizational and management model of clinical trials has not changed significantly. The reason for this is because the industry is notoriously conservative, risk-averse, and highly...
May 27, 2019 | Articles, Case Study, Company News, Genius Suite
Exom implements a digital application in every clinical trial. This is a virtual assistant that shows the investigator all the activities planned by the trial protocol that he must carry out. Digital assistants are identified by many names: chatbot, virtual...
